Skyepharma might be bid target for rival
Skyepharma, a listed UK-based pharmaceuticals group, might attract a takeover bid from a larger rival, according to a Daily Mail market report. The newspaper did not cite a source for the rumour.
The item mentioned market chatter that one of Skyepharma’s partners, such as GlaxoSmithkline of the UK, France’s Sanofi or the Swiss pharmaceuticals group Roche might be keen to acquire Skyepharma. Alternatively, a US-based rival could make an offer, the article added.
Skyepharma’s share price closed 3p up at 304p in London yesterday, 10 April, giving the company a market capitalisation of GBP 318m (EUR 438m).
Daily Mail